HCPCS J3490: Unclassified Drugs
HCPCS Level II code J3490 denotes unclassified drugs and is applied when a specific HCPCS drug code is not available. Nationally, J3490 serves as a catch‑all billing pathway for novel, off‑label, or otherwise unlisted medications administered in outpatient settings, making it consequential for reimbursement workflows, prior authorization processes, and claims adjudication. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, United Healthcare, and Medicare. Readers will find a concise explanation of what J3490 represents, typical clinical and billing contexts where it appears, and comparisons to related unclassified or compounded drug codes used in outpatient claims. The publication outlines common payer considerations and claims handling practices, highlights clinical scenarios that commonly trigger use of J3490, and summarizes coding relationships relevant to pharmacy and outpatient providers. Content addresses coding scope, typical sites of service, and how J3490 fits within broader drug billing workflows without providing clinical or legal advice. Data not available in the input is explicitly noted where applicable.
Sign up for hcpcs J3490 policy alerts
Get alerted when payer policies referencing J3490 are released or updated.
Billing Code Overview
HCPCS Level II code J3490 is designated for unclassified drugs. This code is used to report single drug administrations or drug supplies when no specific HCPCS Level II code exists for the medication provided.
-
Service type: Drug administration / pharmacy-dispensed drug supply
-
Typical site of service: Hospital outpatient departments, physician offices, ambulatory infusion centers, and other outpatient settings where medications without an assigned HCPCS Level II code are administered or supplied.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with multiple chronic conditions presents to the outpatient infusion clinic for receipt of a physician-administered medication that does not have a specific HCPCS level II code. The medication is billed using J3490 (unclassified drugs). The patient is established on long-term therapy documented with Z79.899 and attends periodic visits for therapeutic drug level monitoring (Z51.81). During a recent dosing visit the patient experienced new symptoms consistent with a drug reaction; the provider documents an adverse effect encounter using T50.905A. The clinical workflow includes: medication order entry by the prescribing family medicine or internal medicine physician, pharmacist verification and preparation, nursing administration in the clinic or physician office, documentation of lot number and dose, monitoring for immediate adverse effects, and scheduling follow-up for therapeutic drug monitoring or dose adjustment. Billing captures the unclassified drug using J3490, appropriate service modifiers to reflect site or circumstance, and the relevant diagnosis codes for the visit and ongoing therapy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
JW | Drug amount discarded/not administered | Use when a portion of a single-use vial is discarded after administration and payor requires reporting of waste. |
JZ | No drug administration – no waste to report | Use when drug ordered but not administered (e.g., patient refusal) and documentation supports no administration. |
59 | Distinct procedural service | Use when J3490 is reported on the same date as another payable service that is separate and distinct. |
76 | Repeat procedure by same provider | Use when the same drug administration is repeated later the same day by the same provider. |
77 | Repeat procedure by another provider | Use when the same drug administration is repeated by a different provider on the same day. |
90 | Reference (outside) laboratory | Use when an external laboratory performs therapeutic drug level monitoring billed separately. |
91 | Repeat clinical diagnostic laboratory test | Use when therapeutic drug level testing is repeated and billed. |
25 | Significant, separately identifiable evaluation and management service | Use when an E/M visit on the same day is unrelated to the administration and is separately documented. |
59 | Distinct procedural service | Use to indicate a distinct service when multiple services on the same date might bundle (listed above for emphasis). |
52 | Reduced services | Use when only part of the drug or service was performed compared to full definition (document rationale). |
GA | Waiver of liability statement on file | Use when the provider has signed Advance Beneficiary Notice and reports voluntary payer denial acknowledgement. |
GY | Item or service statutorily excluded or does not meet definition of any Medicare benefit | Use when payor determines drug is non-covered by statute. |
QW | CLIA-waived test | Use when a waived point-of-care therapeutic drug level test is performed in conjunction and requires this modifier per payor rules. |
AS | Physician assistant, nurse practitioner, or clinical nurse specialist services in designated health professional shortage areas | Use when applicable per provider credentials and site designation. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
3336C0003X | Pharmacist | Medication verification, preparation, compounding oversight, documentation of lot numbers. |
207Q00000X | Family Medicine Physician | Prescribing and overall management of chronic therapy and adverse effect evaluation. |
207R00000X | Internal Medicine Physician | Prescribing, monitoring, and management of complex adult chronic drug therapy. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
Z79.899 | Other long term (current) drug therapy | Indicates ongoing chronic medication therapy for which an unclassified drug may be used or continued. |
T50.905A | Adverse effect of unspecified drugs, initial encounter | Documents an acute adverse reaction prompting evaluation at the time of administration or follow-up. |
Z51.81 | Encounter for therapeutic drug level monitoring | Justifies laboratory monitoring related to dosing of medications billed with J3490. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
J7999 | Compounded drug, not otherwise classified | Closely related when the administered unclassified drug is a compounded preparation billed separately as a compounded product. |